Hengrui Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HENGRUI PHARMA, and what generic and branded alternatives to HENGRUI PHARMA drugs are available?
HENGRUI PHARMA has eighteen approved drugs.
Drugs and US Patents for Hengrui Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hengrui Pharma | GADOBUTROL | gadobutrol | SOLUTION;INTRAVENOUS | 216081-004 | Nov 17, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Hengrui Pharma | GADOTERATE MEGLUMINE | gadoterate meglumine | SOLUTION;INTRAVENOUS | 215304-004 | Apr 11, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Hengrui Pharma | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 209065-003 | Jun 12, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.